Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactNew perspectives in occult hepatitis C virus infectionCellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Occult HCV Infection: The Current State of KnowledgeCellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the LiverCombined Hepatitis C Virus (HCV) Antigen-Antibody Detection Assay Does Not Improve Diagnosis for Seronegative Individuals with Occult HCV InfectionClearance of low levels of HCV viremia in the absence of a strong adaptive immune responseAcute hepatitis C virus infection: A chronic problemAdaptive immune responses in acute and chronic hepatitis C virus infectionImmunotherapy for HCV infection: next steps.Occult infection with hepatitis C virus: friend or foe?Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohortAcute hepatitis C virus infection in incarcerated injection drug users.Hepatitis C virus-specific T-cell immune responses in seronegative injection drug usersThe Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patientsLoss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.Hepatitis infection in the treatment of opioid dependence and abuse.Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccineHepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected]Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infectionCharacterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.Hepatitis C virus-specific immune responses in noninjecting drug users.Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.Protective immunity against hepatitis C virus infection.Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virusThe natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineTH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study.Ever closer to a prophylactic vaccine for HCV.Immune responses during acute and chronic infection with hepatitis C virus.Prisons and HCV: a review and a report on an experience in New South Wales Australia.Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.Type III Interferons in Hepatitis C Virus Infection.Progress towards a hepatitis C virus vaccine.
P2860
Q22299128-8D47A825-D170-43F9-A4AB-636B8782D85BQ22305491-5D85DEC9-C978-44F9-B176-AF3860AD7BFDQ26749249-124DDF66-4AB8-4409-8CB7-72901AB34A24Q26770595-F65E8CC5-E864-4778-9B31-EA521F063B23Q27477613-DACDAF46-DB13-42E4-B3A7-8158FC9EA81AQ27477774-076FB366-213B-4A8F-997A-414D418846E3Q27480809-35574080-A00A-416A-BCC8-B37516C4AF98Q27485639-88F0C92C-2E44-4379-9259-DF9E1E901045Q29619722-C177E709-0308-4EB8-A875-5D7DF2958D80Q30371832-2174CD15-39E7-4C82-AFA6-391D10E4F12CQ30416187-91ACA298-3EB2-4C43-8635-50811534B3FAQ30842338-F6581556-112E-4CE0-B3F8-739940209061Q33724826-BD282BAB-267A-46D4-A50A-244CF0C710E2Q33995930-79F96C90-E79C-4156-B040-87C4A71A5442Q34381567-97EB514A-4E13-41E9-A0A3-28A6887454CDQ34481429-04A15DF0-561A-47FD-8C16-06D5888E5032Q34612510-135B0B9F-5040-4419-830C-D790F3379B0AQ34701250-7D6D4868-B0B7-4C20-BE2A-C9FE16207247Q34764010-CA669E5C-956C-4067-9F9C-D10808FD0E1AQ34764025-C83A3890-02E8-4B67-81AA-34AEC9BAB7B2Q35056682-CBAF85B8-4846-41D6-96AB-AC9C58147B82Q35389163-8AC31810-2081-408E-AFA1-7242D3EFE19FQ35771272-15B60836-3443-4939-B278-F2FBF91686BFQ35802129-A47D54F1-7A49-464E-82FF-7321FA90CF88Q35940716-F6B91D1C-64C4-4782-B62A-76AB891DA696Q36013764-587F4C6E-EB16-484F-98B2-89C1CE01B01AQ36168745-05AB77FD-4FE1-4D91-B029-3BE225751B34Q36208809-1FEC44E1-D4A7-4AB5-923A-15F4DD232E32Q36272388-DCA49AC3-FA81-474D-8CD1-1F42C8C7E72AQ36410459-70340687-B0A8-4879-9EC1-E13D9B22A813Q36479225-448838CF-3365-48CF-8814-CDD3C55BEBEAQ36538481-7B83805D-C907-4A21-BCC7-22AE0C7764A0Q36717008-DF77CB00-45F7-4220-AEF9-3D4CE7DB8556Q36849397-1BB83341-8CCD-4E83-A3A1-DA70864611F1Q37089122-9EC5D7BA-D0F0-4917-9E17-927B35F1CC7AQ37178225-DFD7DCBB-7D39-4A0B-88EE-754556E79E22Q37242489-8220B892-49B1-485E-B341-08BD7012BC8BQ37358617-77C0797A-9D60-46FB-BEE4-30022233A9D1Q37528605-F47C2325-9EFA-4751-AFD8-FB1C58997C21Q37584338-A7E71F99-D8EE-4A95-9C75-D87188202AF3
P2860
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@en
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@nl
type
label
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@en
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@nl
prefLabel
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@en
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@nl
P2093
P50
P356
P1476
Clearance of hepatitis C virem ...... ssion in prisons study cohort.
@en
P2093
Anthony J Freeman
Charles E Harvey
George Marinos
Hepatitis C Incidence and Transmission in Prisons Study (HITS) Group
John M Kaldor
Michael H Levy
Patricia Palladinetti
Paul S Haber
Rosemary A Ffrench
P304
P356
10.1086/383279
P407
P577
2004-04-26T00:00:00Z